Actavis Approved for Generic Opana ER

Actavis announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for Oxymorphone Hydrochloride Extended-release Tablets 5mg, 10mg, 20mg, 30mg, and 40mg, the generic equivalent to Endo Health Solution's Opana ER.

RELATED CHART: Narcotic Analgesics

Opana ER is an opioid agonist indicated for the relief of moderate to severe pain in patients requiring continuous around-the-clock opioid treatment for an extended period of time.

Actavis is already marketing Oxymorphone Hydrochloride Extended-release Tablets 7.5mg and 15mg.

For more information call (800) 432-8534 or visit Actavis.us.